Performance Review Board Members, 54510 [2022-19177]

Download as PDF 54510 Federal Register / Vol. 87, No. 171 / Tuesday, September 6, 2022 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Medicare & Medicaid Services Performance Review Board Members Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice. The Centers for Disease Control and Prevention (CDC) located within the Department of Health and Human Services (HHS) is publishing the names of the Performance Review Board Members who are reviewing performance of Senior Executive Service (SES) members, title 42 (T42) executives, and Senior Level (SL) employees for Fiscal Year 2022. FOR FURTHER INFORMATION CONTACT: Henry Greene, Team Chief, Executive and Scientific Resources Office, Human Resources Office, Centers for Disease Control and Prevention, 11 Corporate Square Blvd., Mailstop US11–2, Atlanta, Georgia 30341, Telephone (770) 488– 1140. Title 5, U.S.C. 4314(c) (4) of the Civil Service Reform Act of 1978, Public Law 95–454, requires that the appointment of Performance Review Board Members be published in the Federal Register. The following persons will serve on the CDC Performance Review Board, which will oversee the evaluation of performance appraisals of Senior Executive Service members for the Fiscal Year 2022 review period: jspears on DSK121TN23PROD with NOTICES SUPPLEMENTARY INFORMATION: Bornstein, Joshua, Co-Chair Bonander, Jason Dulin, Stephanie Durst, Kelley Ethier, Kathleen, Co-Chair Kuhnert, Wendi Lindsey, Ronney L. Peeples, Amy Perry, Terrance Philip, Celeste M Tomlinson, Hank Wharton, Melinda Dated: August 29, 2022. Angela K. Oliver, Executive Secretary, Centers for Disease Control and Prevention. [FR Doc. 2022–19177 Filed 9–2–22; 8:45 am] BILLING CODE 4163–18–P 20:04 Sep 02, 2022 Medicare and Medicaid Program; Approval of Application From Det Norske Veritas for Continued Hospital Accreditation Program Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Final notice. AGENCY: SUMMARY: VerDate Sep<11>2014 [CMS–3424–FN] Jkt 256001 This final notice announces our decision to approve Det Norske Veritas for continued recognition as a national accrediting organization for hospitals that wish to participate in the Medicare or Medicaid programs. DATES: The decision announced in this final notice is effective through September 26, 2026. FOR FURTHER INFORMATION CONTACT: Joy Webb, (410) 786–1667. Lillian Williams, (410) 786–8636. SUPPLEMENTARY INFORMATION: SUMMARY: I. Background Under the Medicare program, eligible beneficiaries may receive covered services from a hospital, provided that certain requirements are met. Section 1861(e) of the Social Security Act (the Act), establishes distinct criteria for facilities seeking designation as a hospital. Regulations concerning provider agreements are at 42 CFR part 489 and those pertaining to activities relating to the survey and certification of facilities are at 42 CFR part 488. The regulations at 42 CFR part 482 specify the minimum conditions that a hospital must meet to participate in the Medicare program. Generally, to enter into an agreement, a hospital must first be certified by a State survey agency as complying with the conditions or requirements set forth in part 482 of our regulations. Thereafter, the hospital is subject to regular surveys by a State survey agency to determine whether it continues to meet these requirements. Section 1865(a)(1) of the Act provides that, if a provider entity demonstrates through accreditation by an approved national accrediting organization (AO) that all applicable Medicare conditions are met or exceeded, we may deem those provider entities as having met the requirements. Accreditation by an AO is voluntary and is not required for Medicare participation. If an AO is recognized by the Secretary of the Department of Health PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 and Human Services as having standards for accreditation that meet or exceed Medicare requirements, any provider entity accredited by the national accrediting body’s approved program may be deemed to meet the Medicare conditions. A national AO applying for approval of its accreditation program under part 488, subpart A, must provide the Centers for Medicare and Medicaid Services (CMS) with reasonable assurance that the AO requires the accredited provider entities to meet requirements that are at least as stringent as the Medicare conditions. Our regulations concerning the approval of accrediting organizations are set forth at § 488.5. The regulations at § 488.5(e)(2)(i) require AOs to reapply for continued approval of its accreditation program every 6 years or sooner as determined by CMS. Det Norske Veritas’s (DNV’s) current term of approval for their hospital accreditation program expires September 26, 2022. II. Application Approval Process Section 1865(a)(3)(A) of the Act provides a statutory timetable to ensure that our review of applications for CMS approval of an accreditation program is conducted in a timely manner. The Act provides us 210 days after the date of receipt of a complete application, with any documentation necessary to make the determination, to complete our survey activities and application process. Within 60 days after receiving a complete application, we must publish a notice in the Federal Register that identifies the national accrediting body making the request, describes the request, and provides no less than a 30day public comment period. At the end of the 210-day period, we must publish a notice in the Federal Register approving or denying the application. III. Provisions of the Proposed Notice On April 18, 2022, we published a proposed notice in the Federal Register (87 FR 22894), announcing DNV’s request for continued approval of its Medicare hospital accreditation program. In the proposed notice, we detailed our evaluation criteria. Under section 1865(a)(2) of the Act and in our regulations at § 488.5, we conducted a review of DNV’s Medicare hospital accreditation renewal application in accordance with the criteria specified by our regulations, which include, but are not limited to, the following: • An administrative review of DNV’s—(1) corporate policies; (2) financial and human resources available to accomplish the proposed surveys; (3) procedures for training, monitoring, and evaluation of its hospital surveyors; (4) E:\FR\FM\06SEN1.SGM 06SEN1

Agencies

[Federal Register Volume 87, Number 171 (Tuesday, September 6, 2022)]
[Notices]
[Page 54510]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19177]



[[Page 54510]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Performance Review Board Members

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) located 
within the Department of Health and Human Services (HHS) is publishing 
the names of the Performance Review Board Members who are reviewing 
performance of Senior Executive Service (SES) members, title 42 (T42) 
executives, and Senior Level (SL) employees for Fiscal Year 2022.

FOR FURTHER INFORMATION CONTACT: Henry Greene, Team Chief, Executive 
and Scientific Resources Office, Human Resources Office, Centers for 
Disease Control and Prevention, 11 Corporate Square Blvd., Mailstop 
US11-2, Atlanta, Georgia 30341, Telephone (770) 488-1140.

SUPPLEMENTARY INFORMATION: Title 5, U.S.C. 4314(c) (4) of the Civil 
Service Reform Act of 1978, Public Law 95-454, requires that the 
appointment of Performance Review Board Members be published in the 
Federal Register. The following persons will serve on the CDC 
Performance Review Board, which will oversee the evaluation of 
performance appraisals of Senior Executive Service members for the 
Fiscal Year 2022 review period:

Bornstein, Joshua, Co-Chair
Bonander, Jason
Dulin, Stephanie
Durst, Kelley
Ethier, Kathleen, Co-Chair
Kuhnert, Wendi
Lindsey, Ronney L.
Peeples, Amy
Perry, Terrance
Philip, Celeste M
Tomlinson, Hank
Wharton, Melinda

    Dated: August 29, 2022.
Angela K. Oliver,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2022-19177 Filed 9-2-22; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.